Auto Droplet Generator

Background
The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) is part of the National Institutes of Health and focuses on studying pancreatic islet organoids derived from induced pluripotent stem cells to investigate molecular pathways associated with type 2 diabetes.

The laboratory has recently acquired a QX600 Droplet Digital Polymerase Chain Reaction system to enhance their research capabilities. Bio-Rad Laboratories, Inc. is the sole source identified for the Auto Droplet Generator, which is essential for automating droplet generation in their workflows.

Work Details
The contract involves the procurement of an Auto Droplet Generator that will automate droplet generation for droplet digital polymerase chain reaction workflows.

This system aims to reduce hands-on processing time and improve throughput and consistency across experiments involving pancreatic islets and islet organoids. The Auto Droplet Generator will replace the current Manual Droplet Generator, which can only process up to eight samples at a time, making it inefficient for preparing a full 96-well plate.

Period of Performance
The anticipated award will be issued approximately five days after the notice date.

Place of Performance
Bethesda MD 20892 UNITED STATES

Bidder Requirements
Bio-Rad Laboratories, Inc. is identified as the only known responsible source capable of providing the Auto Droplet Generator that meets NIDDK's standards. Other small businesses may submit a written capability statement demonstrating their ability to meet the requirements.